Free Trial

Charles Schwab Investment Management Inc. Has $72.15 Million Holdings in Chemed Co. (NYSE:CHE)

Chemed logo with Medical background
Remove Ads

Charles Schwab Investment Management Inc. grew its holdings in Chemed Co. (NYSE:CHE - Free Report) by 10.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 136,182 shares of the company's stock after purchasing an additional 13,394 shares during the period. Charles Schwab Investment Management Inc. owned about 0.90% of Chemed worth $72,149,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the business. SRS Capital Advisors Inc. increased its holdings in shares of Chemed by 39.2% in the 4th quarter. SRS Capital Advisors Inc. now owns 135 shares of the company's stock valued at $72,000 after purchasing an additional 38 shares during the period. US Bancorp DE increased its holdings in shares of Chemed by 1.9% in the 4th quarter. US Bancorp DE now owns 4,129 shares of the company's stock valued at $2,187,000 after purchasing an additional 77 shares during the period. Maripau Wealth Management LLC acquired a new position in shares of Chemed in the 4th quarter valued at about $358,000. Argonautica Private Wealth Management Inc. increased its holdings in shares of Chemed by 7.2% in the 4th quarter. Argonautica Private Wealth Management Inc. now owns 505 shares of the company's stock valued at $268,000 after purchasing an additional 34 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in shares of Chemed by 3.5% in the 4th quarter. Bank of New York Mellon Corp now owns 142,255 shares of the company's stock valued at $75,366,000 after purchasing an additional 4,838 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Remove Ads

View Our Latest Analysis on CHE

Chemed Stock Performance

Shares of NYSE CHE opened at $598.12 on Wednesday. The stock has a market cap of $8.75 billion, a price-to-earnings ratio of 30.22, a PEG ratio of 2.15 and a beta of 0.43. The business has a 50 day simple moving average of $555.23 and a 200 day simple moving average of $564.08. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be paid a $0.50 dividend. The ex-dividend date is Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed's payout ratio is 10.05%.

Insider Activity at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the sale, the chief executive officer now owns 102,679 shares of the company's stock, valued at $60,957,441.93. This represents a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Brian C. Judkins bought 145 shares of the firm's stock in a transaction on Monday, December 30th. The shares were bought at an average cost of $519.50 per share, with a total value of $75,327.50. Following the transaction, the vice president now directly owns 1,678 shares of the company's stock, valued at approximately $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.32% of the stock is currently owned by company insiders.

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads